Nature Communications·23 SepPlasma metabolomic signatures enable the diagnosis and prognosis of chronic obstructive pulmonary diseaseStudy in peopleBiomarkersPaper
CA·9 SepEarly stage nonsmall cell lung cancer: Toward a risk-adaptive paradigm in the era of biologic precisionReviewInterventionsPaper